Close Menu

    Subscribe to Updates

    Get the latest information from JBUON.

    What's Hot

    Multiple Head and Neck Cancers: Molecular and Immunologic underpinnings

    July 12, 2025

    Clinical Staging, Histopathological Features and Treatment Outcomes in Malignant Melanoma: A 10-Year Retrospective Single-Center Study

    July 12, 2025

    Two Cases of Pancreatic Metastases from Renal Cell Carcinoma and Review of the Literature

    April 17, 2025
    Facebook X (Twitter) Instagram
    JBUONJBUON
    • How to Submit
    • Author Guidelines
    Facebook X (Twitter) Instagram
    SUBMIT
    • Home
    • Browse Issues
      • In Press
      • Current Issue
      • Archives
    • About Journal
      • Journal Information
      • Editorial Board
      • Bibliographic Listings
      • Editorial Policy
      • Ethics and Malpractice Statement
    • For Authors
      • How To Submit
      • Submit Article
      • Downloads
    • Contact
    JBUONJBUON
    Home»Editorial Board

    Editorial Board

    Editor-in-Chief

     

    Associate Editors

    • Sinisa Radulovic, Institute for Oncology and Radiology of Serbia, Pasterova 14, Belgrade, 11000
    • Lei Yang, Nanjing Medical University, China
    • Strashimir Karanov, National Cancer Center hospital, Sofia, 1756 Bulgaria
    • Munir Kinay, Chairman of Dokuz Eylul University Oncology Institute at Dokuz Eylul University, Izmir, Turkey
    • Dimitrios Trafalis, Medical Oncologist at University of Athens, School of Medicine, Athens, Greece
    • Dimitrios Moris, Department of Surgery, Duke University Medical Center, Durham, NC, USA

     

    Editorial Office: editorial_office@jbuon.com

    Editorial Board

    • Vasile Musteata, State University of Medicine and Pharmacy, ‘N Testemitanu’, Institute of Oncology, Chisinau, Republic of Moldova.
    • P. Achimas-Cadariu, Faculty of Medicine, “Iuliu Hațieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania
    • M. Alakavuklar, Department of Medical Oncology, Kent Hospital, Izmir, Turkey
    • I. Alexandru, Ion Chiricuta Institute of Oncology, Cluj-Napoca, Romania
    • K. Altundag, MKA Breast Cancer Clinic, Ankara, Turkey
    • G. Androutsos, Biomedical Research Foundation, Academy of Athens, Athens, Greece
    • R. Anghel, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania
    • J.P. Armand, Medical Oncology, Institute Gustave Roussy and Institute Curie, Toulouse, France
    • J.O. Armitage, University of Nebraska Medical Center, Omaha, USA
    • N. Arsenijević, Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
    • R.C. Bast Jr, Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, USA
    • A. Bikfalvi, University of Bordeaux, Pessac, France
    • G. Bogdanović, Department of Experimental Oncology, Institute of Oncology Sremska Kamenica, Serbia
    • N. Bountouroglou, Department of Radiation Oncology-A, Metaxa Cancer Hospital, Piraeus, Greece
    • M. Branković-Magić, Institute for Oncology and Radiology of Serbia, Beograd, Yugoslavia
    • S. Brkić, University of Novi Sad, Faculty of Medicine, Serbia
    • P.A. Bunn Jr, Division of Medical Oncology, University of Colorado, Denver, USA
    • K. Christov, Department of Surgical Oncology and Cancer Center, University of Illinois at Chicago, Chicago, USA
    • T. Ciuleanu, Oncology Institute Ion Chiricuta, Cluj-Napoca, Romania
    • D. Delgado, Health & Territory Research of the Universidad de Sevilla, Seville, Spain
    • H.-J. Li, Affiliated 5 to Nantong University, Taizhou, China
    • V. Diehl, University Clinics Cologne, Koln, Germany
    • C. Dittrich, Kaiser Franz Josef-Spital, Vienna, Austria
    • T. Dragovich, University of Arizona Cancer Center, Tucson, USA
    • I. Duran, Hospital Universitario Virgen del Rocio, Seville, Spain
    • A. Eniu, Department of Breast Tumours, Cancer Institute Ion Chiricuta, Cluj-Napoca, Romania
    • S. Filipović, University of Nis, Faculty of Medicine, Clinic of Oncology, Nis, Serbia
    • E.J. Freirech, The University of Texas, MD Anderson Cancer Center, Houston, USA
    • X.-J. Cao, Jiangsu Province Hospital, Nanjing, China
    • C. Gavrilovic, Institute for Oncology and Radiology of Serbia, Beograd, Serbia
    • G. Geromichalos, Laboratory of Inorganic Chemistry, Faculty of Chemistry, Aristotle University of Thessaloniki, Thessaloniki, Greece
    • L. Gocheva, University Hospital “Queen Giovanna-ISUL” Department of Radiotherapy, Sofia, Bulgaria
    • A. Perin, Institute for Pulmonary Diseases of Vojvodina, University of Novi Sad, Topolsica, Slovenia
    • A. Grivas, Department of Medical Oncology, Metaxa Cancer Hospital, Piraeus, Greece
    • S. Guadagni, Department of Applied Clinical Sciences and Biotechnology, University of L’Aquila, L’Aquila, Italy
    • S.Guler, Kocaeli University Medical Faculty, Dept.of General Surgery, Izmir, Turkey
    • H. Hansen, Department of Oncology, Finsen Centre, Copenhagen, Denmark
    • A. Haydaroglu, Department of Radiation Oncology, Ege University Faculty of Medicine, Izmir, Turkey
    • J.C. Holland, Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, USA
    • J.C. Horiot, Centre Georges-François Leclerc, Dijon, France
    • R. Igić, Department of Anesthesiology and Pain Management, Stroger Hospital of Cook County, Chicago, USA
    • A. Irimie, Department of Surgery, The Oncology Institute “Prof. Dr. Ion Chiricuta”, Cluj-Napoca, Romania
    • L. Wan, Huai’an First People’s Hospital, Nanjing Medical University, Huai’an, China
    • G. Karikas, Department of Medical Laboratories, Faculty of Health and Caring Professions, Technological Educational Institute of Athens, Athens, Greece
    • S.B. Kaye, Department of Medical Oncology, University of Glasgow, Garcube Estate, Glasgow, UK
    • A. Klein, Institute of Oncology, Meir Medical Center, Kfar Saba, Israel
    • M. Kontos, First Department of Surgery, ‘Laikon’ General Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
    • E. Lianos, Department of Medical Oncology A’, “Metaxa” Cancer Hospital, Piraeus, Greece
    • S. Linardopoulos, The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK
    • I. Lubinski, Pomeranian Medical University, Department of Genetics and Pathology, International Hereditary Cancer Center, Szczecin, Poland
    • V. Malamou-Mitsi, Department of Pathology, University of Ioannina School of Medicine, Ioannina, Greece
    • M. Malumbres, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas, Madrid, Spain
    • L. Yang, Nanjing Medical University, Nanjing, China
    • A. Mandić, University of Novi Sad, School of Medicine, Novi Sad, Serbia
    • G. Marjanović, Department of Haematology and Clinical Immunology, Clinical Center Nis and Medical Faculty, University of Nis, Nis, Serbia
    • J. Meletis, First Department of Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, Laikon General Hospital, Athens, Greece
    • L. Miron, Department of Clinics, Faculty of Veterinary Medicine, Iasi, Romania
    • A. Molassiotis, School of Nursing, Midwifery and Social Work, University of Manchester, Manchester, UK
    • A. Nersesyan, Institute of Cancer Research, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria
    • L. Ozguroglu, Istanbul University, Cerrahpasa Medical Faculty, Division of Medical Oncology, Istanbul, Turkey
    • A.D. Purushotham, Cambridge Breast Unit, Addenbrookes Hospital, Cambridge, UK
    • D. Radosavljević, Department of Medical Oncology, University of Belgrade, Belgrade, Serbia
    • D. Raghavan, Cleveland Clinic Taussig Cancer Center, 9500 Euclid Avenue Cleveland, Ohio, USA
    • G. Rigatos, St. Savas Anticancer Hospital, Athens, Greece
    • S. Ruacan, Department of Pathology, Medical Faculty of Hacettepe University, Ankara, Turkey
    • P. Rusu, Department of Radiotherapy, Institute of Oncology Prof. Ion Chiricuta, Cluj-Napoca, Romania
    • S. Sahin, Diskapi Yildirim Beyazit Training and Research hosp., Dept of Medical Oncology, Ankara, Turkey
    • M. Sakizli, Medical Biology and Genetics Department, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey
    • M.A.N Sendur, Faculty of Medicine, Department of Medical Oncology, Ankara City Hospital, Ankara Yildirim Beyazit University, Ankara, Turkey
    • J.F. Smyth, Cancer Research Centre Western General Hospital, University of Edinburgh, Edinburgh, UK
    • D. Spandidos, Medical School, University of Crete, Heraklion, Crete, Greece
    • J. Syrios, Department of Medical Oncology A’, “Metaxa” Cancer Hospital, Athens, Greece
    • I. Tannock, Division of Medical Oncology, Princess Margaret Cancer Centre and University of Toronto, Toronto, Canada
    • L. Teppo, Finnish Cancer Registry, Helsinki, Finland
    • A. Thanos, Department of Urology, General Hospital of Athens, Athens, Greece
    • E. Tsiambas, Department of Cytology, 417 Veterans Army Hospital (NIMTS), Athens, Greece
    • D. Tural, Department of Internal Medicine, Division of Medical Oncology, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey
    • A.T. Van Oosterom, Department of Oncology, University Hospitals Leuven, Leuven, Belgium
    • J.B. Vermorken, Department of Medical Oncology, Antwerp University Hospital, Edegem, Belgium
    • S.G. Vitale, University of Messina, Catania, Italy
    • C. Vlad, Department of Oncology, “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania
    • P.A. Voûte, Emma Kinderziekenhuis, Academic Medical Center, Amsterdam, The Netherlands
    • E. Wagner, Nanosystems Initiative Munich (NIM), Munich, Germany
    • J. Tang, Department of Plastic Surgery, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
    • D. Yannoukakos, Molecular Diagnostics Laboratory, I/RRP, National Centre for Scientific Research Demokritos, Athens, Greece
    • Alparslan Merdin, Hematology Clinic and Bone Marrow Transplantation Unit, Ankara, Turkey
    • R.F. Ozols, Medical Science Department, Fox Chase Cancer Center, Philadelphia, USA
    • G. Panagos, Department of Medical Oncology, Agii Anargiri Cancer Hospital, Kifisia, Athens, Greece
    • H.M. Pinedo, Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands
    Don't Miss
    Volume 28, 2025

    Multiple Head and Neck Cancers: Molecular and Immunologic underpinnings

    July 12, 2025

    Eleni Litsou1*, Anna Goussia2, Vasileios Ragos3, Georgios Katiniotis4 and George Zarkavelis5 Author informationCitations 1Department of…

    Clinical Staging, Histopathological Features and Treatment Outcomes in Malignant Melanoma: A 10-Year Retrospective Single-Center Study

    July 12, 2025

    Two Cases of Pancreatic Metastases from Renal Cell Carcinoma and Review of the Literature

    April 17, 2025

    Exploration of Matrix Metalloproteinase-9 and Interleukin-8 in Breast Cancer Patients with No Lymph Node Involvement

    March 14, 2025
    Our Picks

    MicroRNA signatures landscape in renal cell carcinoma – related epithelial to mesenchymal transition

    December 1, 2021

    Chromosomal instability landscape in uveal melanoma

    December 1, 2021

    Biomarkers and common oral cancers: Clinical trial studies

    December 1, 2021

    Subscribe to Updates

    About Us
    About Us

    Journal of BUON (Print ISSN: 1107-0625, Electronic ISSN: 2241-6293) is an independent Open Access Journal, published by BAKIS Productions LTD, and appears exclusively on the internet. It is covered/indexed in Current Awareness in Biological Sciences (BIO-BASE), EMBASE/Excerpta Medica.
    We're accepting new manuscripts right now.

    Email Us: editorial_office@jbuon.com
    Contact: Available soon

    Editorial Picks

    MicroRNA signatures landscape in renal cell carcinoma – related epithelial to mesenchymal transition

    December 1, 2021

    Chromosomal instability landscape in uveal melanoma

    December 1, 2021

    Biomarkers and common oral cancers: Clinical trial studies

    December 1, 2021
    Get in Touch

    Editor-in-Chief
    Athanasios E. Athanasiou,
    Department of Medical Oncology,
    Metaxa Cancer Hospital, Botassi 51, 18537, Piraeus, Greece
    Editorial Office: editorial_office@jbuon.com

    Publishing support
    EManuscript Technologies
    # 9, First Floor, Vinnse Towers
    Wheeler Road Extension, St. Thomas Town, Bangalore 560 084, INDIA
    E: journals@emanuscript.in 
    W : www.emanuscript.in

     

    • Home
    • Author Guidelines
    • Site Map
    • Contact Us
    © 2025 JBUON Powered by EManuscript.

    Type above and press Enter to search. Press Esc to cancel.